ZOONO GROUP LIMITED — Capital/Financing Update 2017

Aug 13, 2017

Zoono Group Limited

ABN: 73 006 645 754 Level 12 225 George Street Sydney NSW 2000 T: +61 (2) 8042 8481 www.zoono.com

==> picture [58 x 59] intentionally omitted <==

ASX RELEASE

14 August 2017

UNMARKETABLE PARCEL SHARE SALE FACILITY COMPLETED

Zoono Group Limited (ASX: ZNO) is pleased to advise the completion of the unmarketable parcel share sale facility as announced on 9 June 2017.

ASX Listing Rules defines an Unmarketable Parcel as those with a market value of less than $500. As at market close on 7 June 2017 ( Closing Date ), there were 2,316 shareholders of unmarketable parcels, representing 431,298 ordinary shares.

166 Zoono holders elected to retain their shareholdings. The remaining unmarketable parcels, representing a total of 317,226 shares, were sold on market on 7 August. The average sale price was $0.2252 per share.

Cheques for the proceeds from the share sale were mailed to those shareholders who participated in the Unmarketable Parcel Share Sale Facility on Friday, 11 August.

For further information please contact:

Elissa Hansen, Company Secretary on 0411 764 556 Or visit www.zoono.com

About Zoono:

Zoono specialises in the development, manufacture and global distribution of a suite of proven, long lasting and environmentally friendly antimicrobial solutions. It has developed products, including aerosol-based sprays, suited for skin care, surface sanitisers, treatment of acne and mould remediation. The products are based around the “Zoono Molecule”; a unique, antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. It has proven efficacy, longevity and, importantly, it does not leach. Zoono products are currently sold in many countries.